{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:06:53Z","timestamp":1788916013836,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Public welfare project of Lishui Science and Technology Bureau","award":["2023GYX69"],"award-info":[{"award-number":["2023GYX69"]}]},{"name":"Zhejiang Medical and Health Science Project","award":["2023RC114"],"award-info":[{"award-number":["2023RC114"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04446-9","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:24:58Z","timestamp":1782368698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A fatty acid metabolism\u2013based deep learning model predicts biochemical recurrence and identifies NUDT19 as a candidate metabolic factor in prostate cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Qin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Zhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"6","key":"4446_CR1","doi-asserted-by":"publisher","first-page":"101692","DOI":"10.1016\/j.gendis.2025.101692","volume":"12","author":"G Du","year":"2025","unstructured":"Du G, Huang X, Su P, Yang Y, Chen S, Huang T et al The role of SOX transcription factors in prostate cancer: Focusing on SOX2. Genes Dis. 2025;12(6):101692. https:\/\/doi.org\/10.1016\/j.gendis.2025.101692.","journal-title":"Genes Dis"},{"issue":"1","key":"4446_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41420-025-02528-3","volume":"11","author":"G Yu","year":"2025","unstructured":"Yu G, Chen K, Xu B, Cao Q, Mitochondrial. SLC25A10 promotes prostate cancer progression by inhibiting ferritinophagy. Cell death discovery. 2025;11(1):242. https:\/\/doi.org\/10.1038\/s41420-025-02528-3.","journal-title":"Cell death discovery"},{"issue":"1","key":"4446_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41420-025-02354-7","volume":"11","author":"G Wei","year":"2025","unstructured":"Wei G, Huang Y, Li W, Xie Y, Zhang D, Niu Y, et al. SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance. Cell death discovery. 2025;11(1):75. https:\/\/doi.org\/10.1038\/s41420-025-02354-7.","journal-title":"Cell death discovery"},{"issue":"1","key":"4446_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41420-025-02904-z","volume":"12","author":"Y Mao","year":"2025","unstructured":"Mao Y, Leng Q, Wu J, Chen W, Lin C, Deng Z, et al. CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1. Cell death discovery. 2025;12(1):45. https:\/\/doi.org\/10.1038\/s41420-025-02904-z.","journal-title":"Cell death discovery"},{"issue":"2","key":"4446_CR5","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.gendis.2025.101732","volume":"13","author":"X Li","year":"2026","unstructured":"Li X, Shen Y, Zhang N, Lu D, Ding S, Wu F, et al Integrative high-throughput studies to develop novel targets and drugs for the treatment of advanced prostate cancer. Genes Dis. 2026;13(2):101732. https:\/\/doi.org\/10.1016\/j.gendis.2025.101732.","journal-title":"Genes Dis"},{"issue":"1","key":"4446_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41420-025-02597-4","volume":"11","author":"C Macedo-Silva","year":"2025","unstructured":"Macedo-Silva C, Albuquerque-Castro \u00c2, Carri\u00e7o I, Lencart J, Carneiro I, Altucci L, et al Decoding MUC1 and AR axis in a radiation-induced neuroendocrine prostate cancer cell-subpopulation unveils novel therapeutic targets. Cell death discovery. 2025;11(1):306. https:\/\/doi.org\/10.1038\/s41420-025-02597-4.","journal-title":"Cell death discovery"},{"issue":"1","key":"4446_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41420-025-02774-5","volume":"11","author":"F Firdaus","year":"2025","unstructured":"Firdaus F, Napoles OC, Dulce RA, Edupuganti A, Kumar S, Shah K, et al Targeting endoplasmic reticulum stress and nitroso-redox imbalance in neuroendocrine prostate cancer: the therapeutic role of nitric oxide. Cell death discovery. 2025;11(1):502. https:\/\/doi.org\/10.1038\/s41420-025-02774-5.","journal-title":"Cell death discovery"},{"issue":"1","key":"4446_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41420-025-02792-3","volume":"11","author":"F Rantanen","year":"2025","unstructured":"Rantanen F, Murum\u00e4gi A, Arjama M, V\u00e4lim\u00e4ki K, Multam\u00e4ki E, Mirtti T, et al Molecular profiling of ex vivo prostate cancer CAF models captures stromal heterogeneity and drug vulnerabilities. Cell death discovery. 2025;11(1):507. https:\/\/doi.org\/10.1038\/s41420-025-02792-3.","journal-title":"Cell death discovery"},{"issue":"4","key":"4446_CR9","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.gendis.2024.101463","volume":"12","author":"M Yeon","year":"2025","unstructured":"Yeon M, Lee AR, Yoo Y, Kim WK, Shin HB, Kook HU, et al Proteomic profiling of exosomes leads to the identification of a candidate biomarker for prostate cancer progression. Genes Dis. 2025;12(4):101463. https:\/\/doi.org\/10.1016\/j.gendis.2024.101463.","journal-title":"Genes Dis"},{"issue":"6","key":"4446_CR10","doi-asserted-by":"publisher","first-page":"101689","DOI":"10.1016\/j.gendis.2025.101689","volume":"12","author":"H Wang","year":"2025","unstructured":"Wang H, Liang S, Du X, Zhao G, Bai Y, Li J, et al RAB26 promotes prostate cancer progression via the MAPK\/ERK-TWIST1 signaling axis. Genes Dis. 2025;12(6):101689. https:\/\/doi.org\/10.1016\/j.gendis.2025.101689.","journal-title":"Genes Dis"},{"issue":"1","key":"4446_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12874-018-0482-1","volume":"18","author":"JL Katzman","year":"2018","unstructured":"Katzman JL, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol. 2018;18(1):24. https:\/\/doi.org\/10.1186\/s12874-018-0482-1.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"4446_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.celrep.2018.03.086","volume":"23","author":"J Saltz","year":"2018","unstructured":"Saltz J, Gupta R, Hou L, Kurc T, Singh P, Nguyen V, et al Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. Cell Rep. 2018;23(1):181\u2013e1937. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.086.","journal-title":"Cell Rep"},{"key":"4446_CR13","doi-asserted-by":"publisher","first-page":"217441","DOI":"10.1016\/j.canlet.2025.217441","volume":"611","author":"MT Hindes","year":"2025","unstructured":"Hindes MT, McElligott AM, Best OG, Ward MP, Selemidis S, Miles MA, et al Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer. Cancer Lett. 2025;611:217441. . https:\/\/doi.org\/10.1016\/j.canlet.2025.217441.","journal-title":"Cancer Lett"},{"issue":"7","key":"4446_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41419-024-06893-2","volume":"15","author":"CL Bidgood","year":"2024","unstructured":"Bidgood CL, Philp LK, Rockstroh A, Lehman M, Nelson CC, Sadowski MC, et al Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer. Cell Death Dis. 2024;15(7):513. https:\/\/doi.org\/10.1038\/s41419-024-06893-2.","journal-title":"Cell Death Dis"},{"key":"4446_CR15","doi-asserted-by":"publisher","first-page":"101925","DOI":"10.1016\/j.tranon.2024.101925","volume":"44","author":"G Wei","year":"2024","unstructured":"Wei G, Zhu H, Zhou Y, Pan Y, Yi B, Bai Y Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer. Translational Oncol. 2024;44:101925. https:\/\/doi.org\/10.1016\/j.tranon.2024.101925.","journal-title":"Translational Oncol"},{"issue":"1","key":"4446_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12935-025-03698-x","volume":"25","author":"B Jin","year":"2025","unstructured":"Jin B, Miao Z, Pan J, Zhang Z, Yang Y, Zhou Y, et al. The emerging role of glycolysis and immune evasion in ovarian cancer. Cancer Cell Int. 2025;25(1):78. https:\/\/doi.org\/10.1186\/s12935-025-03698-x.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"4446_CR17","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912\u20139. https:\/\/doi.org\/10.1080\/09553002.2019.1589653.","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"4446_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jcb.10708","volume":"91","author":"A Baron","year":"2004","unstructured":"Baron A, Migita T, Tang D, Loda M Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem. 2004;91(1):47\u201353. https:\/\/doi.org\/10.1002\/jcb.10708.","journal-title":"J Cell Biochem"},{"issue":"1","key":"4446_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12894-024-01524-6","volume":"24","author":"AR Hsieh","year":"2024","unstructured":"Hsieh AR, Luo YL, Bao BY, Chou TC Comparative analysis of genetic risk scores for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy. BMC Urol. 2024;24(1):136. https:\/\/doi.org\/10.1186\/s12894-024-01524-6.","journal-title":"BMC Urol"},{"issue":"1","key":"4446_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","volume":"26","author":"GS Gulati","year":"2025","unstructured":"Gulati GS, D\u2019Silva JP, Liu Y, Wang L, Newman AM Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics. Nat Rev Mol Cell Biol. 2025;26(1):11\u201331. . https:\/\/doi.org\/10.1038\/s41580-024-00768-2.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4446_CR21","doi-asserted-by":"publisher","unstructured":"Song MG, Bail S, Kiledjian M. Multiple Nudix family proteins possess mRNA decapping activity. RNA (New York, N.Y.). 2013;19(3):390\u20139. https:\/\/doi.org\/10.1261\/rna.037309.112.","DOI":"10.1261\/rna.037309.112"},{"issue":"8","key":"4446_CR22","doi-asserted-by":"publisher","first-page":"110488","DOI":"10.1016\/j.jbc.2025.110488","volume":"301","author":"J Zhong","year":"2025","unstructured":"Zhong J, Liu X, Wang J, Liu H, Liu G, Wen X, et al Zinc oxide nanoparticles disrupt peroxisome-endoplasmic reticulum contacts and increase very-long-chain fatty acid content. J Biol Chem. 2025;301(8):110488. https:\/\/doi.org\/10.1016\/j.jbc.2025.110488.","journal-title":"J Biol Chem"},{"issue":"215","key":"4446_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-3-7091-1368-4_3","volume":"215","author":"MV Airola","year":"2013","unstructured":"Airola MV, Hannun YA. Sphingolipid metabolism and neutral sphingomyelinases. Handb Exp Pharmacol. 2013;215(215):57\u201376. https:\/\/doi.org\/10.1007\/978-3-7091-1368-4_3.","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"4446_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, et al Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell death discovery. 2025;11(1):244. https:\/\/doi.org\/10.1038\/s41420-025-02503-y.","journal-title":"Cell death discovery"},{"issue":"1","key":"4446_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Feng W, Tan Y, Qiao J, Liu H, Liu Q, et al. Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway. J translational Med. 2025;23(1):581. https:\/\/doi.org\/10.1186\/s12967-025-06596-y.","journal-title":"J translational Med"},{"issue":"5","key":"4446_CR26","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J. Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis. 2025;12(5):101529. https:\/\/doi.org\/10.1016\/j.gendis.2025.101529.","journal-title":"Genes Dis"},{"issue":"1","key":"4446_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, Zhang G, Zhang C, Liao Z, et al. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma. Cell death discovery. 2024;10(1):198. https:\/\/doi.org\/10.1038\/s41420-024-01962-z.","journal-title":"Cell death discovery"},{"issue":"1","key":"4446_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer. Cell death discovery. 2025;11(1):262. https:\/\/doi.org\/10.1038\/s41420-025-02536-3.","journal-title":"Cell death discovery"},{"issue":"1","key":"4446_CR29","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2026","unstructured":"Liu C, Wang S, Zhang X, Han Y, Tan M, Fan J, et al. The biomechanical signature of tumor invasion. Genes Dis. 2026;13(1):101771. https:\/\/doi.org\/10.1016\/j.gendis.2025.101771.","journal-title":"Genes Dis"},{"issue":"1","key":"4446_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, Liu J, Zeng G, Li H, et al. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. J translational Med. 2025;23(1):548. https:\/\/doi.org\/10.1186\/s12967-025-06526-y.","journal-title":"J translational Med"},{"issue":"1","key":"4446_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang H, Mao D, Che X, Chen Y, Liu Y. Understanding pre-metastatic niche formation: implications for colorectal cancer liver metastasis. J translational Med. 2025;23(1):340. https:\/\/doi.org\/10.1186\/s12967-025-06328-2.","journal-title":"J translational Med"},{"issue":"3","key":"4446_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/metabo16030170","volume":"16","author":"A Makis","year":"2026","unstructured":"Makis A, Hatzimichael E, Palianopoulos T, Papagiannaki D, Kapsali E, Gikas E, et al Serum Metabolomic Signatures Indicate Oxidative Membrane Lipid Remodeling in \u03b2-Thalassemia. Metabolites. 2026;16(3). https:\/\/doi.org\/10.3390\/metabo16030170.","journal-title":"Metabolites"},{"issue":"1","key":"4446_CR33","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1002\/imt2.70003","volume":"4","author":"X Song","year":"2025","unstructured":"Song X, Qiao L, Dou X, Chang J, Zeng X, Deng T, et al. Hypertriglyceridemia-modulated gut microbiota promotes lysophosphatidylcholine generation to aggravate acute pancreatitis in a TLR4-dependent manner. iMeta. 2025;4(1):e70003. https:\/\/doi.org\/10.1002\/imt2.70003.","journal-title":"iMeta"},{"issue":"15","key":"4446_CR34","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1042\/CS20210468","volume":"135","author":"JF da Silva","year":"2021","unstructured":"da Silva JF, Alves JV, Silva-Neto JA, Costa RM, Neves KB, Alves-Lopes R, et al. Lysophosphatidylcholine induces oxidative stress in human endothelial cells via NOX5 activation - implications in atherosclerosis. Clin Sci (London England: 1979). 2021;135(15):1845\u201358. https:\/\/doi.org\/10.1042\/CS20210468.","journal-title":"Clin Sci (London England: 1979)"},{"issue":"4","key":"4446_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/01.cir.98.4.353","volume":"98","author":"M Kohno","year":"1998","unstructured":"Kohno M, Yokokawa K, Yasunari K, Minami M, Kano H, Hanehira T, et al. Induction by lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, of human coronary artery smooth muscle cell migration. Circulation. 1998;98(4):353\u20139. https:\/\/doi.org\/10.1161\/01.cir.98.4.353.","journal-title":"Circulation"},{"issue":"3","key":"4446_CR36","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1182\/blood-2004-05-1916","volume":"105","author":"LV Yang","year":"2005","unstructured":"Yang LV, Radu CG, Wang L, Riedinger M, Witte ON. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood. 2005;105(3):1127\u201334. https:\/\/doi.org\/10.1182\/blood-2004-05-1916.","journal-title":"Blood"},{"issue":"9","key":"4446_CR37","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1074\/jbc.m706586200","volume":"283","author":"C Peter","year":"2007","unstructured":"Peter C, Waibel M, Radu C, Yang L, Witte O, Schulze-Osthoff K, et al. Migration to Apoptotic Find-me Signals Is Mediated via the Phagocyte Receptor G2A. J Biol Chem. 2007;283(9):5296\u2013305. https:\/\/doi.org\/10.1074\/jbc.m706586200.","journal-title":"J Biol Chem"},{"issue":"2","key":"4446_CR38","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.5489\/cuaj.4600","volume":"12","author":"DJ Khalaf","year":"2018","unstructured":"Khalaf DJ, Avil\u00e9s CM, Azad AA, Sunderland K, Todenh\u00f6fer T, Eigl BJ, et al. A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Can Urol Association J = J de l\u2019Association des urologues du Can. 2018;12(2):E47\u201352. https:\/\/doi.org\/10.5489\/cuaj.4600.","journal-title":"Can Urol Association J = J de l\u2019Association des urologues du Can"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04446-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04446-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04446-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:29:05Z","timestamp":1788913745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04446-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4446"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04446-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Participants enrolled in the clinical cohort provided written informed consent prior to enrollment. The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Lishui Central Hospital, Lishui, China (Approval number: LSCHEC\u20112024\u2011348). All animal procedures were approved by the Institutional Animal Care and Use Committee of the Hangzhou Institute of Medicine, Chinese Academy of Sciences (Approval number: AP2025\u201104\u20110504). Informed consent was obtained from all participants involved in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"365"}}